School Of Medicine

Benign lesions caused by a common fungus can mimic those caused by cancer in the lungs. A Vanderbilt research team is on the hunt for a non-invasive way for doctors to tell the two diseases apart. Read More

Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases. Read More

Using a unique computational framework they developed, a team of scientist cyber-sleuths in the Vanderbilt University Department of Molecular Physiology and Biophysics and the Vanderbilt Genetics Institute has identified 104 high-risk genes for schizophrenia. Read More

A team of researchers from Vanderbilt University’s schools of law, medicine and management has received a five-year research grant from the Agency for Healthcare Research and Quality of the Department of Health and Human Services to develop and test “safe harbor” standards of care based on scientific evidence. Read More

Eric Skaar and colleagues have figured out how a common bug responsible for ventilator-associated pneumonia responds when starved of zinc, a metal it needs to survive, which may lead to new therapeutic targets for the dangerous infection. Read More

A report by researchers at Vanderbilt University Medical Center has shattered conventional wisdom about how cells, including cancer cells, shed DNA into the bloodstream. Read More

Jonathan Schoenecker, Stephanie Moore-Lotridge and colleagues have found a new target for treating a condition that causes bone to form in soft tissue, reducing mobility. Read More

Austin Kirschner and colleagues are learning more about how the cancer drug enzalutamide combines with radiation therapy to treat difficult prostate tumors. Read More

Gabriela Alvarado began her graduate program intent on studying something microscopic, but she ended up developing a passion for understanding the bigger picture of her research. Read More

Like many medical students, Kathleen Gallagher knew by the time she’d finished high school biology that she wanted to become a doctor. It was the tragedy of Sept. 11, however, that launched her journey into trauma surgery. Read More

Chancellor Nicholas S. Zeppos presented prestigious university awards to seven faculty members honored for their contributions and commitment to the university at the Spring Faculty Assembly. Read More

A commonly used muscle relaxant can cause severely low blood pressure in patients already taking a CYP1A2 inhibitor, such as ciprofloxacin, find Cecilia Chung and colleagues. Read More

Jonathan Soslow and colleagues have found more clues to why people with Duchenne muscular dystrophy are at risk for a certain kind of heart problem. Read More

Stephen Fesik and colleagues have uncovered more details about how a crucial component of RAS proteins, which trigger about a third of all tumors, work. This finding will help advance the discovery of new cancer therapies. Read More

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered. Read More

VUMC has received significant grants to study pulmonary fibrosis, a progressive and irreversible disease characterized by shortness of breath and a dry cough. Read More

Jason McGurn and colleagues have uncovered new insights into the complex and highly coordinated endocytic trafficking mechanism, which is an essential part of many cellular processes including sodium resorption by the kidney and regulation of blood plasma sodium levels. Read More

A $3.4 million grant from the National Institute of Mental Health will fund Vanderbilt research on treatment resistance in patients with major depressive disorder and schizophrenia. Read More

Commonly thought to be harmless, enlargement of fluid-filled in the brain have been linked to cognitive problems in older adults. Read More

A March 28 town hall with several university leaders will focus on two studies for capital improvements: one for facility needs in the science and engineering disciplines, and the other to revitalize the A&S historic core buildings. Read More